Cantor Fitzgerald Reiterates Overweight Rating on Tenax Therapeutics (TENX) Sep 10, 2026 09:24AM
Tenax Therapeutics (TENX) Reiterated at Overweight by Cantor Fitzgerald: Ph3 Data in Q3 Jun 24, 2026 06:50AM
Cantor Fitzgerald Starts Tenax Therapeutics (TENX) at Overweight Mar 17, 2026 06:34AM
Pre-Market Technical Scan on Biotech Equities -- Ignyta, Pluristem Therapeutics, Ritter Pharma, and Tenax Therapeutics Jan 8, 2018 07:00AM